image
Karyopharm Therapeutics Inc. KPTI
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.814
-2.78 %
$ 102 M
Market Cap
-0.78
P/E
BALANCE SHEET
240 M ASSETS
-32.87%
Growth Rates
1Year -32.87%
3Years -8.42%
5Years -6.76%
7Years 4.19%
10Years 4.27%
377 M LIABILITIES
0.48%
Growth Rates
1Year 0.48%
3Years 12.79%
5Years 18.97%
7Years 54.23%
10Years 60.64%
-136 M EQUITY
-717.76%
Growth Rates
1Year -717.76%
3Years -54.59%
5Years -11.76%
7Years -9.10%
10Years -6.51%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Karyopharm Therapeutics Inc.
image
Current Assets 234 M
Cash & Short-Term Investments 192 M
Receivables 27 M
Other Current Assets 14.9 M
Non-Current Assets 6.52 M
Long-Term Investments 0
PP&E 4.88 M
Other Non-Current Assets 1.64 M
Current Liabilities 69.5 M
Accounts Payable 3.12 M
Short-Term Debt 6.62 M
Other Current Liabilities 59.7 M
Non-Current Liabilities 307 M
Long-Term Debt 174 M
Other Non-Current Liabilities 133 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 52.2 135.2 190.5 85.9 128.9 118.0 69.0 49.7 58.4 150.6 156.0 0.4 6.5
Short Term Investments 139.2 142.8 38.2 163.3 133.1 210.2 77.5 79.9 117.3 55.1 0 0 0
Receivables 27.0 47.1 22.5 12.9 7.9 0 0 0 0 0 0 0 0
Inventory 3.0 4.2 4.1 2.6 0.3 0 0 0 0 0 0 0 0
Other Current Assets 11.8 20.9 20.4 11.8 8.4 12.8 3.7 4.2 3.9 4.1 4.0 0.6 0.4
Total Current Assets 233.9 326.8 258.1 289.5 273.7 334.6 148.4 131.6 177.6 207.8 158.0 1.0 6.9
PP&E 4.9 7.4 1.6 2.2 3.0 3.9 2.2 2.8 3.5 2.8 0.2 0.3 0.3
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.6 0.6 24.2 2.0 2.0 29.4 45.4 33.9 8.7 0 0 0
Other Long Term Assets 1.6 23.4 44.9 (2.9) 16.2 0.7 0.3 0.5 0.5 1.2 30 K 30 K 30 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 240.4 358.2 305.3 313.1 295.0 341.2 180.3 180.4 215.4 220.3 158.2 1.3 7.2
LIABILITIES
Accounts Payable 3.1 2.8 1.6 4.5 1.0 4.3 5.7 4.8 3.8 6.3 1.7 1.1 1.1
Short Term Debt 6.6 5.7 4.6 3.8 3.3 0 0 0 0 0 0 0 0
Other Current Liabilities 59.7 57.4 67.5 51.6 39.7 33.2 21.9 11.7 11.3 6.0 1.5 0.8 0.8
Total Current Liabilities 69.5 65.9 73.7 0.3 46.4 46.9 49.5 16.5 15.1 12.3 2.9 1.9 2.1
Long Term Debt 173.7 176.2 178.3 129.2 123.1 102.7 0 0 0 0 0 0 0
Deferred Tax Income 0 (132.7) (133.0) (73.1) 73.6 (93.5) 0 0 0 0 0 0 0
Other Liabilities 133.5 132.7 133.0 73.1 0 3.9 1.4 1.7 0 1.2 (0.4) 27.3 17.8
Total Liabilities 376.6 374.8 385.0 262.5 245.2 158.0 50.8 18.1 17.1 13.5 3.3 29.2 19.9
EQUITY
Common Stock 12 K 12 K 8 K 7 K 7 K 6 K 5 K 4 K 4 K 3 K 3 K 0 0
Retained Earnings (1 487.0) (1 343.9) (1 178.6) (1 069.6) (873.3) (673.7) (495.3) (366.1) (256.5) (138.3) (62.6) (28.6) (12.7)
Other Accumulative Comprehensive Income/Loss (0.2) (0.6) 0.2 0.5 37 K (0.2) (0.2) (0.3) (0.3) 29 K (0.3) (0.2) 84 K
Total Equity (136.2) (16.7) (79.7) 50.5 49.8 183.2 129.5 162.2 198.4 206.8 154.9 (27.9) (12.7)
Total Liabilities and Equity 240.4 358.2 305.3 313.1 295.0 341.2 180.3 180.4 215.4 220.3 158.2 1.3 7.2
SHARES OUTSTANDING
Common Shares Outstanding 114.2 81.9 75.2 72.0 62.0 56.8 45.9 37.5 35.6 31.1 6.1 2.4 1.0